Join the Diabetes, Type 2 group to help and get support from people like you.
Diabetes, Type 2 News (Page 10)
Related terms: Noninsulin-dependent Diabetes, Type 2 Diabetes, Diabetes, Type 2
Too Little Sleep Might Raise a Woman's Odds for Diabetes
TUESDAY, Nov. 14, 2023 – Women who don’t get enough sleep might have an increased risk of diabetes, an effect even more pronounced in postmenopausal females, a new study finds. Shortening sleep by j...
American Academy of Ophthalmology, Nov. 3-5
The annual meeting of the American Academy of Ophthalmology was held from Nov. 3 to 5 in San Francisco and attracted participants from around the world, including ophthalmologists, optometrists,...
AHA: Fresh Produce Prescription Improves Glycemic Control
MONDAY, Nov. 13, 2023 – A fresh produce prescription program can significantly improve hemoglobin A1c (HbA1c) among low-income patients with diabetes and poor glycemic control, according to a study...
Science Reveals Link Between Obesity, Diabetes & Pancreatic Cancer Risk
FRIDAY, Nov. 10, 2023 – Having high insulin levels may be more than tough to manage when you have diabetes: New research shows it also appears to raise the risk of pancreatic cancer. In the study,...
Wegovy, Ozempic Probably Won't Harm Vision in People With Diabetes, Study Finds
THURSDAY, Nov. 9, 2023 (HealthDay) – There's good news for people with diabetes who are turning to drugs like Ozempic and Wegovy to treat their disease and lose weight: The drugs probably will not...
AAO: Diabetic Retinopathy Usually No Worse With Semaglutide in T2D
THURSDAY, Nov. 9, 2023 – For patients with type 2 diabetes mellitus, most eyes have no worsening of diabetic retinopathy (DR) after initiation of semaglutide, according to a study presented at the...
FDA Approves New Diet Drug Zepbound, a Version of the Diabetes Med Mounjaro
WEDNESDAY, Nov. 8, 2023 – A second injectable diabetes drug has been approved for weight loss in overweight and obese adults, the U.S. Food and Drug Administration announced Wednesday. The...
FDA Investigating Hospitalizations Linked to Counterfeit Ozempic
WEDNESDAY, Nov 8, 2023 – The U.S. Food and Drug Administration has received at least three reports of people being hospitalized after taking counterfeit versions of the wildly popular weight-loss...
Depression Can Be a Killer for People With Diabetes
TUESDAY, Nov. 7, 2023 – Many people with type 2 diabetes also struggle with depression, and this combination can lead to premature death, researchers say. “More than 35 million Americans have d...
FDA Approves Zituvimet (sitagliptin and metformin hydrochloride) to Treat Adult Patients With Type 2 Diabetes Mellitus
November 06, 2023, Ahmedabad, India -- Zydus Lifesciences Limited (including its subsidiaries/affiliates, hereafter referred to as "Zydus") today announced that the U.S. Food and Drug Administration ...
FDA Medwatch Alert: FDA Warns Consumers of Hidden Drug Ingredients in Dr. Ergin’s SugarMD Advanced Glucose Support
November 3, 2023 -- Consumers should not purchase or use Dr. Ergin’s SugarMD Advanced Glucose Support, a product promoted and sold for blood glucose management. It may have been purchased at ww...
Too Much Salt Could Raise Your Odds for Diabetes
FRIDAY, Nov. 3, 2023 – Put down the saltshaker — especially if you’re at risk of type 2 diabetes. While the condition brings to mind the need to avoid sugar, a new study links it to frequent salt con...
Time-Restricted Eating Effective for Weight Loss, Lowering HbA1c
THURSDAY, Nov. 2, 2023 – A time-restricted eating (TRE) intervention without calorie counting is effective for weight loss and lowering hemoglobin A1c (HbA1c) levels among adults with obesity and...
Fasting Diets Beat Low-Cal Regimens for Folks With Diabetes
MONDAY, Oct. 30, 2023 – Time-restricted dieting may be a better way for people with type 2 diabetes to lose weight than counting calories, a new study suggests. Researchers found that people who...
Diabetes Tied to Worse Outcomes When Colon Cancer Strikes
FRIDAY, Oct. 27, 2023 – Having diabetes and colon cancer together can raise the risk of dying early, particularly for patients with diabetic complications, a new study shows. To arrive at that...
Ask a question
To post your own question to this support group, sign in or create an account.
Further information
Related condition support groups
Related drug support groups
metformin, Ozempic, Victoza, Lantus, Mounjaro, Trulicity, glipizide, semaglutide, Rybelsus, view more... Lantus Solostar, Humalog, Farxiga, Novolog, Jardiance, Janumet, insulin glargine, Januvia, insulin lispro, Bydureon, Tresiba, Levemir, liraglutide, Invokana, Glucophage, Humulin N, insulin degludec